Analysis – Page 2 – Goldea Capital

Diversified Royalty Corp. Announces April 2026 Cash Dividend

Written by Customer Service on April 2, 2026. Posted in Dividend Reports And Estimates.

VANCOUVER, British Columbia, April 02, 2026 (GLOBE NEWSWIRE) — Diversified Royalty Corp. (TSX: DIV, DIV.DB.A and DIV.DB.B) (the “Corporation” or “DIV”) is pleased to announce that its board of directors has approved a cash dividend of $0.02375 per common share for the period of April 1, 2026 to April 30, 2026, which is equal to $0.285 per common share on an annualized basis. The dividend will be paid on April 30, 2026 to shareholders of record as of the close of business on April 15, 2026. About Diversified Royalty Corp. DIV is a multi-royalty corporation, engaged in the business of acquiring top-line royalties from well-managed multi-location businesses and franchisors in North America. DIV’s objective is to acquire predictable, growing royalty streams from a diverse group of multi-location businesses and franchisors. DIV currently...

Weatherford Announces Proposal to Redomesticate to the United States, Establishing Texas as New Legal Domicile

Written by Customer Service on April 2, 2026. Posted in Public Companies.

Move reflects continued execution of Weatherford’s free-cash-flow-focused strategy to streamline corporate structure, enhance capital management flexibility and deliver long-term shareholder value HOUSTON, April 02, 2026 (GLOBE NEWSWIRE) — Weatherford International plc (NASDAQ: WFRD) (“Weatherford” or the “Company”) today announced its proposal to reorganize the Company’s corporate structure by redomesticating its parent company from Ireland to the United States, with Texas as the parent company’s new legal home. The proposed redomestication is expected to be completed in the third quarter of 2026, subject to shareholder and other customary approvals for a transaction of this type. Weatherford’s global operational headquarters has been located in Houston for more than two decades, and the Company maintains a substantial operational,...

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of March 31, 2026

Written by Customer Service on April 2, 2026. Posted in Public Companies.

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of March 31, 2026 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers) Market : NYSE Euronext Paris ISIN Code: FR 0010417345 Date Total number of shares Total number of voting rights03/31/2026 296,042,447 Total gross of voting rights: 296,042,447 Total net* of voting rights: 295,914,379 * Net total = total number of voting rights attached to shares – shares without voting rightsAttachmentPDF Version

Esperion Therapeutics Closes Acquisition of Corstasis Therapeutics, Expanding Its Cardiovascular Franchise with Enbumyst™ (bumetanide nasal spray)

Written by Customer Service on April 2, 2026. Posted in Mergers And Acquisitions.

– Enbumyst, First and Only FDA-Approved Nasal Spray Loop Diuretic Now Integrated into Esperion’s Cardiovascular Franchise, Anticipated to Drive Portfolio Expansion, Commercial Leverage, and Continued Revenue Growth – ANN ARBOR, Mich., April 02, 2026 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR) (the Company) today announced the closing of its acquisition of Corstasis Therapeutics Inc., a privately-held, commercial-stage biopharmaceutical company advancing innovative outpatient therapies for the treatment of edema associated with cardiovascular and hepatic and renal disease. “The closing of this acquisition marks an important milestone in advancing our Vision 2040 and strengthens our commitment to delivering differentiated therapies that address the growing global burden of cardiometabolic disease,” said Sheldon Koenig, President and...

KBR’s Mission Technology Solutions Supports NASA’s Artemis II Mission as Astronauts Embark on Historic Return to the Moon

Written by Customer Service on April 2, 2026. Posted in Public Companies.

HOUSTON, April 02, 2026 (GLOBE NEWSWIRE) — KBR‘s (NYSE: KBR) Mission Technology Solutions business is delivering critical services to support astronauts on NASA’s Artemis II mission as they embark on their journey around the moon – the first human mission beyond low-Earth orbit since Apollo 17 in 1972. From inside Mission Control, KBR teams are providing real-time monitoring and control of spacecraft systems and astronaut health, helping to ensure crew safety and the success of this landmark endeavor. KBR teams are working alongside NASA throughout mission execution, supporting the crew during their 10-day journey. The work is being performed under longstanding KBR contracts that support NASA’s human spaceflight portfolio. “Artemis II highlights the durability and strategic importance of KBR’s human spaceflight portfolio,” said...

American Assets Trust, Inc. Announces First Quarter 2026 Earnings Release Date and Conference Call Information

Written by Customer Service on April 2, 2026. Posted in Public Companies.

SAN DIEGO, April 02, 2026 (GLOBE NEWSWIRE) — American Assets Trust, Inc. (NYSE:AAT) (the “Company”) will announce its first quarter 2026 earnings in a press release to be issued after the market closes on Tuesday, April 28, 2026. Senior management will hold a conference call for its first quarter 2026 earnings on Wednesday, April 29, 2026 at 8:00 a.m. Pacific Time (“PT”). To access the conference call, please dial 1 (833) 816-1162 and ask to join the American Assets Trust, Inc. Conference Call. A live on-demand audio webcast of the conference call will be available on the “Investor Relations” section of the Company’s website at www.americanassetstrust.com. A replay webcast will be available on the Company’s website approximately one hour after the conclusion of the conference call. About American Assets Trust, Inc. American Assets...

Alerus Financial Corporation to Announce First Quarter Financial Results on Wednesday, April 29

Written by Customer Service on April 2, 2026. Posted in Public Companies.

MINNEAPOLIS, April 02, 2026 (GLOBE NEWSWIRE) — Alerus Financial Corporation (Nasdaq: ALRS) announced that it will issue its first quarter financial results on Wednesday, April 29, 2026. Alerus Financial Corporation will also host a conference call at 11:00 a.m. Central Time on Thursday, April 30, 2026, to discuss its financial results. Analysts and institutional investors may participate in the question-and-answer session. Attendees are encouraged to register ahead of time for the call. Conference Call Information Date: Thursday, April 30, 2026 Time: 12:00 p.m. Eastern Time / 11:00 a.m. Central Time Register: https://register-conf.media-server.com/register/BIff30a6d15e4e4b268617d2f78268fe7e A recording of the call and transcript will be available at investors.alerus.com following the call. About Alerus Financial Corporation Alerus...

Riot Announces First Quarter 2026 Production and Operations Updates

Written by Customer Service on April 2, 2026. Posted in Earnings Releases And Operating Results.

CASTLE ROCK, Colo., April 02, 2026 (GLOBE NEWSWIRE) — Riot Platforms, Inc. (NASDAQ: RIOT) (“Riot” or “the Company”), a Bitcoin-driven industry leader in the development of large-scale data centers and bitcoin mining applications, announces unaudited production and operations updates for the first quarter of 2026. Bitcoin Production and Operations Updates for Q1 2026 Comparison (%)Metric Q1 2026 1 Q1 2025 1 Quarter/QuarterBitcoin Produced 1,473 1,530 -4%Average Bitcoin Produced per Day 16.4 17.0 -4%Bitcoin Held 2 15,680 3 19,223 -18%Bitcoin Sold 3,778 – N/ABitcoin Sales – Net Proceeds $289.5 million – N/AAverage Net Price per Bitcoin Sold $76,626 N/A N/ADeployed Hash Rate – Total 2 42.5 E+H/s 33.7 E+H/s 26%Avg. Operating Hash Rate – Total 4 36.4...

Athyrium Capital Management and Esperion Enter Into $50 Million Japan Royalty Financing to Support Strategic Acquisition of Corstasis Therapeutics

Written by Customer Service on April 2, 2026. Posted in Mergers And Acquisitions.

Athyrium Funds purchased a portion of the royalties payable to Esperion on Japan net sales of Otsuka’s bempedoic acid products, together with related milestone payments, subject to a cap, for total consideration of $50 million Athyrium Funds to receive tiered royalties ranging from 12% to 33%, as well as milestone payments, until receiving aggregate payments equal to 2.0x their investment, after which all rights revert to Esperion Financing supports Esperion’s acquisition of Corstasis Therapeutics Inc., which developed and is commercializing Enbumyst™, the first FDA-approved intranasal loop diuretic for treatment of edema associated with cardiovascular and hepatic and renal diseaseNEW YORK and ANN ARBOR, Mich., April 02, 2026 (GLOBE NEWSWIRE) — Athyrium Capital Management, LP and Esperion Therapeutics, Inc. (Nasdaq: ESPR)...

Century Aluminum Applauds President Trump for Executive Order to Fully Enforce Sec. 232 Aluminum Tariffs

Written by Customer Service on April 2, 2026. Posted in Public Companies.

CHICAGO, April 02, 2026 (GLOBE NEWSWIRE) — Century Aluminum Company (NASDAQ: CENX) is applauding President Donald Trump’s new executive order that will close valuation loopholes that importers have been using to avoid the President’s tariffs on steel and aluminum, leveling the playing field for American manufacturers. The Section 232 tariff on primary aluminum is unchanged and remains at 50 percent. Importers had been abusing valuation loopholes to reduce their liability under the President’s steel and aluminum tariffs. In some instances, importers declared only the value of raw steel and aluminum while excluding value added through processing, thereby lowering the tariff owed and disadvantaging domestic manufacturers. The order clarifies that importers must declare the full value of covered products, promoting consistent enforcement...

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals